Author:
Laitinen David L.,Manthena Shivaji
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference51 articles.
1. Davidson M, Meyer PM, Haffner S, et al. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intimamedia thickness progression in patients with type 2 diabetes mellitus. Circulation. 2008;117:2123–2130.
2. Ferns G, Keti V. HDL-cholesterol modulation and its impact on the management of cardiovascular risk. Ann Clin Biochem. 2008;45:122–128.
3. Hausenloy DJ, Yellon DM. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels. Postgrad Med J. 2008;84:590–598.
4. Kim SM, Han JH, Park HS. Prevalence of low HDL-cholesterol levels and associated factors among Koreans. Circ J. 2006;70:820–826.
5. Agoşton-Coldea L, Zdrenghea D, Pop D, Craăiun A, Rusu ML, Mocan T. Prevalence and particularities of dyslipidaemia in subjects with coronary heart disease. Rom J Intern Med. 2007;45:341–347.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献